Battens Disease

Phospholipids, Endosomes and Brain Function in Battens Disease
2006 Seed Grant
Glyn Dawson, Ph.D.
The University of Chicago

Dr. Dawson’s laboratory focuses on Batten disease, a neurodegenerative disease that results in mental retardation and premature death. Batten disease is a lysosomal storage disease in which undigested proteins accumulate inside membrane-bounded organelles in cells called lysosomes. Defects in lysosomal enzymes, that ordinarily breakdown discarded materials, cause a build up of proteins leading to severe pathological consequences (neuronal death). Batten disease is autosomal recessive. Normal adults can be carriers for Batten disease. If both parents carry one defective gene there isa one out of four chance that the fetus will be severely retarded. DNA-based testing can be done on amniotic fluid to determine the mental health of the fetus. Unfortunately, if the test is positive, the parents are now faced with the difficult decision of whether to bring the baby to term. Any intervention that improves the prognosis of this disease would be a welcomed development.

Batten disease involves at least nine different genes and more than 100 different mutations in each gene. This complexity makes Batten disease difficult to cure. Dr. Dawson is trying to reduce the source of accumulated proteins in lysosomes through drug therapy to slow down the disease. His laboratory has been focusing on one mutated enzyme in the disease, palmitoyl protein thioesterase (PPT1). Dr. Dawson’s team synthesized a drug DAPl to block the production of the undigestible proteins. DAPl was not as effective as they had hoped but it did inhibit PPTl and enabled them to create a model for Batten disease in isolated cells. Serendipitously, they found DAPl to be an anti-cancer drug because of its ability to promote cell death. DAPl helped chemotherapeutic drugs such as adriamycin and tamoxifan kill tumor cells. Dr. Dawson is thinking to the future and is working hard to develop a second generation of drugs that will decrease cell death and combat Batten disease.

Other Grants

Sarah C. Goetz, Ph.D., Duke University
Uncovering a Novel Role for Primary Cilia in Eph/Ephrin Signaling in Neurons
2022 Seed GrantSarah C. Goetz, Ph.D. Duke University Women’s Council Seed Grant Primary cilia are tiny projections from cells that function like an antenna- they receive and may also send…
Erin M. Gibson, Ph.D., Stanford University
Circadian Regulation of Oligodendroglial Senescence and Metabolomics in Aging
2022 Seed GrantErin M. Gibson, Ph.D.Stanford University The brain consists of two main classes of cells, neurons and glia. Glia make-up more than half of the cells in the brain…
Yvette Fisher, Ph.D., University of California, Berkeley
Dynamic Modulation of Synaptic Plasticity During Spatial Exploration
2022 Seed GrantYvette Fisher, Ph.D.University of California, Berkeley The Virginia (Ginny) & Roger Carlson Seed Grant Cognitive flexibility is critical for appropriately adjusting thoughts and behaviors to meet changing demands…
Byoung Il Bae, Ph.D., University of Connecticut
Unique Vulnerability of Developing Human Cerebral Cortex to Loss of Centrosomal Protein
2022 Seed GrantByoung Il Bae, Ph.D.University of Connecticut Carl & Marilynn Thoma Foundation Seed Grant The cerebral cortex is the largest and outermost part of the human brain. It is…